Showing results (371-380 of 398) with videos related to

Sort By:
Pageof 40
Arthritis and Rheumatism|February 2, 2012
Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomesCailin H Sibley, Nikki Plass, Joseph Snow, et al.
The EMBO Journal|January 9, 2016
Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signalingCelio X C Santos, Anne D Hafstad, Matteo Beretta, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2017
NLRP3 mutation and cochlear autoinflammation cause syndromic and nonsyndromic hearing loss DFNA34 responsive to anakinra therapyHiroshi Nakanishi, Yoshiyuki Kawashima, Kiyoto Kurima, et al.
Journal of Medical Genetics|September 24, 2011
Allelic hierarchy of CDH23 mutations causing non-syndromic deafness DFNB12 or Usher syndrome USH1D in compound heterozygotesJulie M Schultz, Rashid Bhatti, Anne C Madeo, et al.
Ear and Hearing|September 12, 2024
Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer TreatmentKatharine Fernandez, Alex Hoetink, Dawn Konrad-Martin, et al.
JAMA Health Forum|October 31, 2025
Manifestations of Structural Racism and Inequities in Cardiovascular Health Across US NeighborhoodsWayne R Lawrence, Hyokyoung G Hong, Faustine Williams, et al.
Nature Genetics|August 4, 1999
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiencyA Brooks-Wilson, M Marcil, S M Clee, et al.
Lancet (London, England)|August 15, 2017
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trialDaniel S Ory, Elizabeth A Ottinger, Nicole Yanjanin Farhat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2022
Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genesC Loveday, A Garrett, P Law, et al.
Frontiers in Public Health|October 9, 2025
Community-based participatory design of a decade: the FAITH! Cardiovascular Health and Wellness ProgramLaPrincess C Brewer, Mathias Lalika, Ashley N Kyalwazi, et al.
Pageof 40